Skip to main content
. 2017 Jun 30;7(7):162. doi: 10.3390/nano7070162

Figure 5.

Figure 5

Preliminary toxicological assessment. (a) Hematoxylin-eosin sections from paraffin-embedded tissues (kidney, liver and spleen) of control and treated mice; (b) Plasma and urine levels of renal biomarker (creatinine); (c,d) Plasma levels of systemic inflammation biomarkers (IL-6 and TNF-α); (e) Plasma level of liver biomarker (ALT).